(Press-News.org) Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes of Health and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.
These findings, which will be published in Cell on Sept. 28, could lead to new therapeutic strategies for some cancers.
"We carried out a highly sophisticated analysis of MYC activity in cells, but came away with a simple rule. MYC is not a power switch but a universal amplifier," said co-lead study author Keji Zhao, Ph.D., director of the Systems Biology Center at the NIH's National Heart, Lung, and Blood Institute (NHLBI). "This discovery offers a unifying idea of how and why abnormal levels of MYC are found in so many different cancer types, such as breast cancer, lung cancer, and several blood cancers."
"MYC is much like the volume control of a music player," added co-lead David Levens, M.D., Ph.D., a senior investigator in the Laboratory of Pathology at the National Cancer Institute (NCI), also part of NIH. "If you're listening to opera, for example, adding more MYC will make the opera louder, but it won't change the program to rap. And if you have only silence, MYC will just give you more silence."
Both researchers noted that this new understanding of MYC function could influence future treatment efforts for MYC-associated tumors. They suggest that trying to limit MYC activity, or turning down the volume just the right amount, would be a better strategy than using targeted chemotherapy to try to eliminate all MYC activity.
MYC aids in cell activation, a process in which cells mature and divide quickly. During an immune response, for example, white blood cells are activated to help fight infections. If activation isn't properly regulated, then cells can start growing out of control and result in cancer. Researchers have known that abnormally high levels of MYC can lead to cancer, but until now, no one had been able to explain how it can lead to so many different cancers.
Zhao, Levens, and their colleagues used a specially designed fluorescent protein that allowed them to track MYC in white blood cells in a lab dish. They chose white blood cells, specifically B cells and T cells that fight infections, because they are frequently affected by abnormal MYC and can transform into lymphoma and myeloma cells.
The team exposed the B and T cells to foreign toxins to stimulate an immune response and activate the fluorescent MYC. The researchers could then examine the cells at different time points and see which genes the MYC proteins seemed to affect.
The analysis revealed that MYC didn't prefer any specific type of gene. Instead, MYC proteins were present at nearly every gene that was already expressed, or turned on. The researchers also noticed that the amount of MYC at each expressed gene correlated with how active that gene was prior to immune stimulation. The more active the gene, the more MYC gathered there. MYC appeared to amplify productivity relative to the initial expression levels where it gave a small boost to genes with low activity and a big boost to genes with high activity.
The researchers validated the idea of MYC as a universal amplifier by developing a set of B cells that did not produce functional MYC. When they were stimulated, the total cellular amount of RNA—an indicator of how much protein is being made—did not rise. When normal B cells were activated, the total cellular RNA did rise.
The research team then conducted the same analysis in embryonic stem cells and got similar results.
###In addition to the research teams at the NHLBI and NCI, scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, also part of the NIH, and at St. Jude Children's Research Hospital in Memphis, Tenn., contributed to this study.
For more information or to schedule an interview, contact the NHLBI Communications Office at 301-496-4236 or nhlbi_news@nhlbi.nih.gov or the NCI Office of Media Relations at 301-496-6641 or ncipressofficers@mail.nih.gov.
Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at http://www.nhlbi.nih.gov.
NCI leads the National Cancer Program and the NIH effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI Web site at http://www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH...Turning Discovery Into Health
Researchers have discovered in fruit flies a key metabolic hormone thought to be the exclusive property of vertebrates. The hormone, leptin, is a nutrient sensor, regulating energy intake and output and ultimately controlling appetite. As such, it is of keen interest to researchers investigating obesity and diabetes on the molecular level. But until now, complex mammals such as mice have been the only models for investigating the mechanisms of this critical hormone. These new findings suggest that fruit flies can provide significant insights into the molecular underpinnings ...
CAMBRIDGE, Mass. (September 27, 2012) – For a cancer patient, over-expression of the MYC oncogene is a bad omen.
Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.
The prevailing theory emerging from ...
Chicago (September 27, 2012)—New comprehensive guidelines for the pre- operative care of the nation's elderly patients have been issued by the American College of Surgeons (ACS) and the American Geriatrics Society (AGS). The joint guidelines—published in the October issue of the Journal of the American College of Surgeons—apply to every patient who is 65 years and older as defined by Medicare regulations. The guidelines are the culmination of two years of research and analysis by a multidisciplinary expert panel representing the ACS and AGS, as well as by expert representatives ...
Top box office films last year showed more onscreen smoking than the prior year, reversing five years of steady progress in reducing tobacco imagery in movies, according to a new UCSF study.
Moreover, many of the top-grossing films of 2011 with significant amounts of smoking targeted a young audience, among them the PG-rated cartoon Rango and X-Men: First Class." The more smoking young people see in movies, the more likely they are to start smoking, the U.S. Surgeon General has reported.
The study will be available September 27, 2012 in Preventing Chronic Disease Journal, ...
Biocomposites challenge chipboard as furniture material. Researchers at VTT Technical Research Centre of Finland have developed a kitchen furniture framework material from plastic polymers reinforced with natural fibre. The new material reduces raw materials consumption by 25 per cent and the carbon footprint of production by 35 per cent.
"The frames are lighter by nearly a third because they contain more air," says VTT's Research Professor Ali Harlin. "Wastage during production is also reduced. This is a generational shift that revolutionizes both manufacturing techniques ...
In experiments on mice and rats, the scientists have managed to both prevent the development of type II diabetes and reverse the progression of established disease. The study is published in the prestigious scientific journal Nature, where it is described as a breakthrough in diabetes research. The findings are the result of a joint effort by Karolinska Institutet, the Ludwig Institute for Cancer Research and the Australian biopharmaceutical company CSL Limited, amongst others.
"It's a great feeling to present these results," says Professor Ulf Eriksson of the Department ...
TEMPE, Ariz.-Perhaps inspired by Arizona's blazing summers, Arizona State University scientists have developed a new method that relies on heat to improve the yield and lower the costs of high-energy biofuels production, making renewable energy production more of an everyday reality.
ASU has been at the forefront of algal research for renewable energy production. Since 2007, with support from federal, state and industry funding, ASU has spearheaded several projects that utilize photosynthetic microbes, called cyanobacteria, as a potential new source of renewable, carbon-neutral ...
Similar characteristics have not been observed in other constructions of the Bronze Age, with three-metre thick walls, square towers originally measuring up to seven metres, a monumental entrance and an ogival arched postern gate; a fully conserved architectural element unique in Europe in that period.
The wall protected a city measuring 4 hectares located on top of a hill. With architectural elements reminiscent of people with Eastern styled military skills, its model is typical of ancient civilisations of the Mediterranean, such as the second city of Troy.
The alignment ...
Scientists use simulations to test the limits of their object of study—in this case thin films of polymers—to extremes of scale. In a study¹ about to be published in EPJ E, Nava Schulmann, a researcher at Strasbourg University, France, and colleagues use a well-known model capable of providing information on heat and mechanical energy exchange between these polymer chains. They found that polymer blends confined to ultrathin two-dimensional films displayed enhanced compatibility. This was made possible by simulations using a fairly standard model, which is simple enough ...
Since the Victorian era, categorizing the natural world has challenged scientists. No group has presented a challenge as tricky as the protists, the tiny, complex life forms that are neither plants nor animals. A new reclassification of eukaryotic life forms, published in the Journal of Eukaryotic Microbiology, draws together the latest research to clarify the current state of protist diversity and categorization, as well as the many species that remain to be discovered.
"Protists include species traditionally referred to as protozoa and algae, some fungal-like organisms, ...
